Antitrust Issues in Generic Substitution: How Drug Companies Block Cheaper Alternatives
Drug companies are using legal tricks to block cheaper generics by pulling older drugs off the market just before patents expire. This tactic, called product hopping, costs patients billions and undermines state substitution laws. Here’s how it works - and who’s fighting back.
Read More